A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

NCT00554359 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Injury of Kidney
Acute Renal Failure

Interventions

DRUG: I5NP (a small interfering RNA)
DRUG: placebo

Sponsor

Quark Pharmaceuticals